We are live on ! Find out more
BA

Bennicas & Associates Portfolio holdings

AUM $173M
1-Year Est. Return 1.55%
This Fund
S&P 500
This Quarter Est. Return
-2.01%
1 Year Est. Return
+1.55%
3 Year Est. Return
+40.28%
5 Year Est. Return
+86.07%
10 Year Est. Return
–
AUM
$178M
AUM Growth
-$4.03M
Cap. Flow
+$995K
Cap. Flow %
0.56%
Top 10 Hldgs %
37.36%
Holding
102
New
3
Increased
8
Reduced
41
Closed
3

Top Buys

Rank Stock Value
1
SH icon
ProShares Short S&P500
SH
+$1.37M
2
PBR icon
Petrobras
PBR
+$664K
3
NUE icon
Nucor
NUE
+$346K
4
KL
Kirkland Lake Gold Ltd Ordinary
KL
+$256K
5
TTE icon
TotalEnergies
TTE
+$217K

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$2.01M
2
RTX icon
RTX Corp
RTX
+$730K
3
TGT icon
Target
TGT
+$338K
4
AVA icon
Avista
AVA
+$201K
5
LLY icon
Eli Lilly
LLY
+$163K

Sector Composition

Rank Sector Weight
1 Consumer Staples 19.96%
2 Materials 13.75%
3 Healthcare 11.31%
4 Technology 9.77%
5 Real Estate 6.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GLDD
51
DELISTED
Great Lakes Dredge & Dock
GLDD
$1.21M 0.68%
80,450
+13,000
+19% +$193K
UL icon
52
Unilever
UL
$139B
$1.21M 0.68%
19,756
– –
TEAM icon
53
Atlassian
TEAM
$28.8B
$1.19M 0.67%
3,050
– –
SNY icon
54
Sanofi
SNY
$103B
$1.18M 0.66%
24,425
– –
JNJ icon
55
Johnson & Johnson
JNJ
$621B
$1.16M 0.65%
7,200
-100
-1% -$17.1K
K
56
DELISTED
Kellanova
K
$1.12M 0.63%
18,611
-53
-0.3% -$3.18K
BUD icon
57
AB InBev
BUD
$168B
$1.08M 0.61%
19,150
– –
NUE icon
58
Nucor
NUE
$62.6B
$1.03M 0.58%
10,450
+3,250
+45% +$346K
COP icon
59
ConocoPhillips
COP
$140B
$974K 0.55%
14,378
+500
+4% +$28.9K
REGN icon
60
Regeneron Pharmaceuticals
REGN
$79.1B
$899K 0.51%
1,485
– –
WIP icon
61
State Street SPDR FTSE International Government Inflation-Protected Bond ETF
WIP
$474M
$892K 0.5%
16,400
-1,000
-6% -$56.6K
OXY icon
62
Occidental Petroleum
OXY
$53.5B
$860K 0.48%
29,057
– –
AEM icon
63
Agnico Eagle Mines
AEM
$83.8B
$826K 0.46%
15,937
– –
ASA
64
ASA Gold and Precious Metals
ASA
$1.03B
$784K 0.44%
41,480
-900
-2% -$18.6K
DNP icon
65
DNP Select Income Fund
DNP
$4.03B
$723K 0.41%
67,820
-125
-0.2% -$1.34K
ORCL icon
66
Oracle
ORCL
$416B
$723K 0.41%
8,300
– –
BHP icon
67
BHP
BHP
$227B
$719K 0.4%
15,066
-180
-1% -$11K
DOC icon
68
Healthpeak Properties
DOC
$15B
$698K 0.39%
20,834
-240
-1% -$8.49K
QCOM icon
69
Qualcomm
QCOM
$165B
$674K 0.38%
5,225
– –
EQNR icon
70
Equinor
EQNR
$90.6B
$663K 0.37%
26,000
– –
LEG icon
71
Leggett & Platt
LEG
$1.4B
$650K 0.37%
14,500
– –
PBR icon
72
Petrobras
PBR
$118B
$644K 0.36%
+62,300
New +$664K
RYN icon
73
Rayonier
RYN
$6.62B
$535K 0.3%
16,533
– –
ELAN icon
74
Elanco Animal Health
ELAN
$13.1B
$503K 0.28%
15,770
-2
-0% -$67
AGI icon
75
Alamos Gold
AGI
$13.1B
$466K 0.26%
64,700
– –
1 2
3
4

Similar funds

CCM
Cribstone Capital Management Augusta, Maine $172M AUM 13.58% 1-Year Est. Return
AWM
Aevitas Wealth Management Wellesley Hills, Massachusetts $169M AUM 9.55% 1-Year Est. Return
S
Schroders London, United Kingdom $185M AUM 16.04% 1-Year Est. Return
BFS
Bickling Financial Services Lexington, Massachusetts $160M AUM 18.81% 1-Year Est. Return
SCM
Snowhook Capital Management New York $187M AUM 31.24% 1-Year Est. Return
RCC
Red Cedar Capital Omaha, Nebraska $158M AUM 6.57% 1-Year Est. Return
WWA
WC Walker & Associates Fullerton, California $189M AUM 16.91% 1-Year Est. Return
NEGWA
New England Guild Wealth Advisors Avon, Connecticut $190M AUM 17.1% 1-Year Est. Return

Bennicas & Associates's Q3 2021 Portfolio in Review

As of Q3 2021, Bennicas & Associates held 102 positions worth $178M, down 2.2% from $182M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Bennicas & Associates's Q3 2021 filing shows 3 new, 8 increased, 41 reduced and 3 closed positions. Its largest new stake was Petrobras: 62,300 shares worth $644K. The largest sale was Pfizer, an estimated $2.01M.

By sector, the portfolio is most concentrated in Consumer Staples at 20% of assets, up from 20% a quarter earlier, followed by Materials and Healthcare.

  • Bennicas & Associates's largest Q3 2021 buy was Petrobras: 62,300 shares worth $644K.
  • Bennicas & Associates added most to ProShares Short S&P500 in Q3 2021, an estimated $1.37M increase.
  • Bennicas & Associates's biggest Q3 2021 reduction was Target, cutting an estimated $338K.
  • Bennicas & Associates fully exited Pfizer in Q3 2021, selling an estimated $2.01M.
  • Bennicas & Associates's ten largest holdings make up 37% of its $178M portfolio in Q3 2021.
  • Bennicas & Associates opened 3 new positions and closed 3 in Q3 2021.
  • Bennicas & Associates's portfolio value fell 2.2% quarter-over-quarter to $178M.

Based on Bennicas & Associates's 13F filing for Q3 2021, filed 8 Oct 2021.